MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies Oct 28, 2025 08:00AM
MilliporeSigma to acquire JSR Life Sciences chromatography business Oct 15, 2025 08:01AM
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio Oct 15, 2025 08:00AM
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration Jul 24, 2025 05:00PM
MilliporeSigma Launches AAW™ Workstation to Advance Lab Automation Jul 15, 2025 08:00AM
View Older Stories

Jun 18, 2025 08:00AM MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant
Apr 24, 2025 08:00AM Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students
Jan 23, 2025 08:00AM MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future
Jan 6, 2025 08:00AM MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
Dec 17, 2024 08:00AM MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
Oct 29, 2024 08:01AM MilliporeSigma Invests $76 Million to Expand ADC Manufacturing for Novel Cancer Therapies
Oct 9, 2024 08:01AM MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA
Sep 10, 2024 08:00AM MilliporeSigma Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing
Sep 3, 2024 08:00AM MilliporeSigma Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing
Aug 1, 2024 08:01AM MilliporeSigma Announces Closing of Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering
Jun 18, 2024 08:00AM MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
Jun 4, 2024 08:00AM MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
May 28, 2024 10:04AM MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control
May 22, 2024 01:35PM MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing
Apr 17, 2024 08:00AM MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
Apr 16, 2024 08:00AM MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Mar 20, 2024 11:03AM MilliporeSigma Invests More than € 300 Million in New Life Science Production Site in Korea
Sep 26, 2023 04:00AM MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
Jul 12, 2023 11:30AM MilliporeSigma Invests $25 Million to Expand Cell Culture Media Production in Kansas
Jul 11, 2023 09:05AM Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance
Jun 6, 2023 08:00AM MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant
Mar 27, 2023 08:00AM Merck KGaA, Darmstadt, Germany Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO® (avelumab)
Dec 6, 2022 08:00AM MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition
Nov 16, 2022 08:00AM MilliporeSigma Invests $ 286 Million in U.S. Drug Safety Testing Capacity
Oct 4, 2022 04:30AM MilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore® CTDMO Services
Sep 8, 2022 09:00AM MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
Aug 9, 2022 08:00AM MilliporeSigma Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
Jul 18, 2022 12:00PM MilliporeSigma Breaks Ground on Company's First Lateral Flow Membrane Production Facility in the United States
Jul 13, 2022 09:00AM Micron to Select Athinia™ for Pioneering Data Collaboration
Jun 23, 2022 09:00AM MilliporeSigma Opens US$ 65 Million CDMO Facility to Address Demand for Critical Cancer Therapies
May 18, 2022 08:00AM MilliporeSigma Announces the Expansion of Hands-On Science Education Program with Kick-off of Global Curiosity Cube® Mobile Lab
Apr 5, 2022 02:00PM MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities
Mar 31, 2022 09:00AM EMD Serono Shares Advances in MS Portfolio with Key Efficacy and Safety Data at AAN 2022
Feb 23, 2022 08:40AM MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up
Feb 18, 2022 01:00PM European Commission Approves TEPMETKO® (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations
Feb 7, 2022 09:05AM MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth
Dec 29, 2021 05:15PM MilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin
Dec 17, 2021 07:00AM TEPMETKO® (tepotinib) Receives Positive CHMP Opinion for Patients with Advanced NSCLC with METex14 Skipping Alterations
Nov 18, 2021 09:00AM New Data Show Dramatic Emotional Toll of Pandemic on Unpaid Caregivers of People Living With Cancer, Affecting Mental Health and Relationships
Oct 28, 2021 09:00AM MilliporeSigma Announces New Innovation & Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies
Oct 12, 2021 09:00AM MilliporeSigma Announces Completion of New Viral Vector Contract Development Manufacturing Facility for Gene Therapy
Oct 4, 2021 03:00AM EMD Serono Completes Enrollment of Evobrutinib Phase III Clinical Trials Ahead of ECTRIMS 2021
May 26, 2021 08:00AM MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid-19 Demand
Mar 17, 2021 11:40AM MilliporeSigma Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies
Jan 25, 2021 02:00AM European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Jan 7, 2021 04:00AM MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Dec 11, 2020 08:00AM BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Dec 7, 2020 08:00AM MilliporeSigma Expands Production Capacities
Oct 8, 2020 08:30AM MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant
Oct 6, 2020 01:00PM MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant
View Older Stories